Bo Li
Gladstone Institutes(US)University of California, San Francisco(US)Quantitative BioSciences(US)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer-related molecular mechanisms research, Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer(2017)344 cited
- → Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors(2022)216 cited
- → Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial(2020)201 cited
- → SARS-CoV-2 infection induces beta cell transdifferentiation(2021)190 cited
- → 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents(2018)129 cited
- → NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer(2019)